Sign up to save your podcasts
Or
Share Pure Global's ASEAN MedTech Insights: Navigating the Hemodialysis Machine Market in Malaysia, Thailand, and Vietnam for Global Success
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pure Global's ASEAN MedTech Insights: Navigating the Hemodialysis Machine Market in Malaysia, Thailand, and Vietnam for Global Success
This episode of ASEAN MedTech Insights explores the booming but complex market for hemodialysis machines in Southeast Asia. We uncover the drivers behind the surging demand, such as rising rates of chronic kidney disease in countries like Malaysia, Thailand, and Vietnam, and examine the significant growth opportunities for MedTech manufacturers.
However, the path to market is filled with regulatory hurdles. We break down the fragmented nature of ASEAN's regulatory landscape, where a successful launch in one country does not guarantee success in another. We share a real-world case study of a European company that faced costly delays in Malaysia and Indonesia after underestimating the unique, localized requirements for registration and post-market surveillance, illustrating the critical need for expert local guidance.
What you'll learn in this episode:
- Why is Thailand's universal healthcare system a double-edged sword for hemodialysis device innovators?
- How can a successful registration in Singapore inadvertently complicate your market entry into the Philippines?
- What specific post-market surveillance demands in Malaysia are catching foreign manufacturers off guard?
- Is home hemodialysis a viable market in countries like Indonesia and Vietnam, and what are the regulatory barriers?
- How do you build a technical dossier that can be efficiently adapted for Vietnam, Thailand, and Singapore simultaneously?
- What are the hidden costs of appointing the wrong in-country regulatory representative?
- How do local content and representation requirements in Indonesia create unexpected challenges for device registration?
At Pure Global, we specialize in transforming these regulatory challenges into market opportunities. We provide MedTech and IVD companies with end-to-end regulatory consulting, combining deep local expertise with advanced AI tools to streamline your access to over 30 global markets, including key ASEAN countries. Let us be your local representative and strategic partner. Contact us at [email protected] or visit https://pureglobal.com/ to learn more.
View all episodes
By Ran ChenThis episode of ASEAN MedTech Insights explores the booming but complex market for hemodialysis machines in Southeast Asia. We uncover the drivers behind the surging demand, such as rising rates of chronic kidney disease in countries like Malaysia, Thailand, and Vietnam, and examine the significant growth opportunities for MedTech manufacturers.
However, the path to market is filled with regulatory hurdles. We break down the fragmented nature of ASEAN's regulatory landscape, where a successful launch in one country does not guarantee success in another. We share a real-world case study of a European company that faced costly delays in Malaysia and Indonesia after underestimating the unique, localized requirements for registration and post-market surveillance, illustrating the critical need for expert local guidance.
What you'll learn in this episode:
- Why is Thailand's universal healthcare system a double-edged sword for hemodialysis device innovators?
- How can a successful registration in Singapore inadvertently complicate your market entry into the Philippines?
- What specific post-market surveillance demands in Malaysia are catching foreign manufacturers off guard?
- Is home hemodialysis a viable market in countries like Indonesia and Vietnam, and what are the regulatory barriers?
- How do you build a technical dossier that can be efficiently adapted for Vietnam, Thailand, and Singapore simultaneously?
- What are the hidden costs of appointing the wrong in-country regulatory representative?
- How do local content and representation requirements in Indonesia create unexpected challenges for device registration?
At Pure Global, we specialize in transforming these regulatory challenges into market opportunities. We provide MedTech and IVD companies with end-to-end regulatory consulting, combining deep local expertise with advanced AI tools to streamline your access to over 30 global markets, including key ASEAN countries. Let us be your local representative and strategic partner. Contact us at [email protected] or visit https://pureglobal.com/ to learn more.